Tropical Journal of Pharmaceutical Research

Original Research Article | OPEN ACCESS

Protective effect of ethosuximide on hearing in NOD/LtJ mice via blockage of endogenous apoptosis

Dejun Zhang, Guofang Guan , Yingyuan Guo, Yanru Hao, Fang Guo, Zeming Fu

Department of Otolaryngology, Head and Neck Surgery, The Second Hospital of Jilin University, Changchun, PR China;

For correspondence:- Guofang Guan Email: g779hy@163.com

Accepted: 27 January 2020 Published: 29 February 2020

Citation: Zhang D, Guan G, Guo Y, Hao Y, Guo F, Fu Z. Protective effect of ethosuximide on hearing in NOD/LtJ mice via blockage of endogenous apoptosis. Trop J Pharm Res 2020; 19(2):299-304 doi: 10.4314/tjpr.v19i2.12

© 2020 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To determine the protective effect of ethosuximide on the hearing of NOD/LtJ mice, and the underlying mechanism of action.

Methods: The mice were randomly assigned to control and treatment groups (20 mice per group). Mice in the treatment group were administered ethosuximide intraperitoneally at a dose of 200mg/kg body weight (bwt), while those in the control group received an equivalent dose of saline via the same route. Both groups were subjected to auditory brainstem response (ABR) and distortion product otoacoustic emissions (DPOAE) tests, as well as determination of mRNA expressions of α1G, α1H, α1I, m-calpain, μ-calpain, and caspase-3.

Results: At ages of 6 and 9 weeks, ABR values were significantly lower in the treatment group than those in the control group (p < 0.05). At age 3, 6 and 9 weeks, control group DPOAE values were much lower than those in the treatment group. However, at signal frequency of 35344 Hz, DPOAE value was significantly reduced in the treatment group (p < 0.05). There was significant down-regulation in mRNA expressions of α1G, α1H, α1I, m-calpain, μ-calpain and caspase-3, in the treatment group, when compared with the control group (p < 0.05).

Conclusion: Ethosuximide delays mice hearing loss and protects their hearing via a mechanism involving blockage of endogenous apoptotic pathways. This mechanism may provide guidance in the search for suitable new drugs.

Keywords: Ethosuximide, Endogenous apoptosis, Hearing, Protection